查看購物車
  • English
  • Japanese
核酸樣品製備耗材市場－全球及區域分析：按工作流程、來源、技術、下游應用、最終使用者和國家分類－分析與預測（2025-2035 年）
市場調查報告書
商品編碼
2027381

核酸樣品製備耗材市場－全球及區域分析：按工作流程、來源、技術、下游應用、最終使用者和國家分類－分析與預測（2025-2035 年）

Nucleic Acid Sample Preparation Consumables Market - A Global and Regional Analysis: Focus on Workflow, Source Type, Technology, Downstream Application, End User, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 247 Pages | 商品交期: 1-5個工作天內

價格

2024年全球核酸樣本製備耗材市場規模最初為 17.262億美元，但預計將大幅成長，到2035年將飆升至 28.168億美元，在2025年至2035年期間的年複合成長率將達到驚人的4.37%。

關鍵市場統計資料
預測期 2025-2035
2025年市場規模 18.359億美元
2035年預測 28.168億美元
年複合成長率 4.37%

全球核酸樣本製備耗材市場正經歷強勁成長，這主要得益於對高通量、高精度和擴充性分子工作流程日益成長的需求，而這種需求又源於檢測量的增加以及診斷和研究領域應用範圍的擴大。核酸樣本製備是醫療和生命科學領域，特別是分子診斷、傳染病檢查、腫瘤學和基因組學研究等關鍵上游流程，在這些領域，可靠、高品質的DNA和RNA提取對於上游工程分析非常重要。感染疾病和癌症的日益流行，以及基因檢測和微生物定序應用的不斷擴展，進一步強化了樣本製備耗材在臨床檢查室、研究機構和診斷環境中的作用。自動化技術在樣本製備工作流程中的應用，透過實現萃取流程的標準化、減少人為操作差異和縮短處理時間，改變傳統的實驗室流程。這些耗材在臨床診斷和研究實驗室等高通量環境中尤其重要，因為在這些環境中，一致性、擴充性和準確性非常重要。隨著醫療保健和研究系統向精準醫療和營運效率轉變，先進的自動化耗材的採用加速，以提高可重複性、最佳化工作流程並滿足大規模測試需求。

試劑化學、磁性顆粒技術和自動化耗材的技術進步顯著提升樣本製備能力。著重提高核酸產量、純度和一致性的創新，使得qPCR和次世代定序（NGS）等下游應用性能更優。此外，耗材與自動化提取平台和標準化實驗室工作流程的日益整合，使得跨多個實驗室的可擴展部署成為可能，支援高效、高通量的操作。對實驗室系統間工作流程標準化和互通性的日益重視，進一步加速了從分散的手動流程向整合化、自動化主導的樣本製備解決方案的轉變。然而，市場仍面臨許多挑戰，例如耗材高成本、嚴格的監管和品質合規要求，以及在不同實驗室環境中對標準化工作流程的需求。儘管存在這些挑戰，但基因組研究投入的增加、診斷基礎設施的擴展以及生命科學公司、研究機構和醫療保健提供者之間的策略合作，預計將推動核酸樣本製備耗材市場的持續成長和創新。

市場概覽

由於技術的不斷進步和自動化在實驗室工作流程中的日益普及，全球核酸樣本製備耗材市場發生了顯著變化。各公司正不斷開發即用型、自動化相容的耗材，以提高提取效率、增強結果的可重複性並減少實驗室中的人工勞動。這些創新支持包括分子診斷、基因組學、傳染病檢查和精準醫療在內的廣泛應用，實現更快、更準確、更標準化的檢測結果。

磁珠萃取技術、高效試劑化學和自動化試劑盒等關鍵技術的進步，體現了業界對提升樣品品質、降低污染風險和提高處理效率的重視。此外，樣品製備耗材與自動化平台和數位化實驗室系統的整合，提升整個實驗室的工作流程效率、資料一致性和操作擴充性。

對分子檢測日益成長的需求、基因組學領域研究活動的活性化以及對疾病早期檢測的日益重視，正進一步加速這些技術在已開發市場和新興市場的應用。隨著醫療保健和研究生態系統不斷優先考慮準確性、擴充性和效率，核酸樣本製備耗材的持續創新有望在塑造分子診斷和生命科學工作流程的未來方面發揮關鍵作用。

對產業的影響

受分子診斷技術日益普及、感染疾病和癌症發病率不斷上升以及基因組技術（例如次世代定序（NGS）和基於 PCR 的應用）的廣泛應用等因素的推動，全球核酸樣本製備耗材市場正經歷顯著成長。Thermo Fisher Scientific Inc.、Danaher Corporation、QIAGEN N.V.、F. Hoffmann-La Roche AG、Agilent Technologies, Inc.、Bio-Rad Laboratories, Inc.、Promega Corporation、LGC Biosearch Technologie等主要企業正透過持續創新和策略投資，在推動樣本製備技術發展方面發揮著非常重要的作用。

這些公司正積極致力於開發與自動化相容的耗材、高效提取試劑盒和先進的試劑化學技術，這些技術革新樣本製備流程，並在臨床和研究環境中實現高通量、可重複且擴充性的操作。這些創新提高了核酸的產量、純度和一致性，增強了下游應用（例如qPCR和NGS）的可靠性。

同時，在新興市場需求不斷成長的推動下，製造商開發經濟高效、標準化且易於使用的耗材，以適應資源有限的實驗室環境，擴大分子診斷和基因組研究的覆蓋範圍。耗材製造商、診斷實驗室、研究機構和自動化解決方案供應商之間的策略合作，進一步推動了創新和市場擴張。

此外，樣本製備耗材、自動化平台和標準化工作流程的整合提高了檢查室效率，減少了人工操作時間，最大限度地降低了變異性，支持了高通量檢測環境。總體而言，核酸樣本製備耗材增強了工作流程的可靠性，實現了可擴展的分子檢測，並支持基因組學、診斷學和生命科學生態系統中的廣泛發展。

市場區隔:

細分 1：依來源

  • DNA
  • RNA

DNA領域是核酸樣品製備耗材市場（依來源類型）的主要驅動力。

就原料類型而言，DNA領域預計將推動核酸樣品製備耗材市場的發展，這主要得益於對高品質DNA的需求不斷成長、全球範圍內各種DNA萃取試劑盒的供應，以及NGS、PCR、克隆和限制性內切酶分析等各種下游製程對核酸（尤其是DNA）需求的顯著成長。

細分 2：依工作流程

  • 樣品分離/萃取/純化
  • DNA/RNA純化與富集
  • DNA/RNA定量

「樣品分離、萃取和純化」推動核酸樣品製備耗材市場（依工作流程）。

從工作流程的角度來看，樣品分離、萃取和純化預計將推動核酸樣品製備耗材市場的發展。這些過程耗材消耗量極大，每個樣本都需要多種試劑和拋棄式零件，且耗材消耗量與檢測量成正比。

細分3：依技術

  • 二氧化矽基技術
  • 磁粉技術
  • 其他技術

在核酸樣品製備耗材市場（依技術），磁性顆粒技術可望佔據主導地位。

從技術角度來看，磁性顆粒技術因其高結合效率、穩定的產量以及與自動化、高通量工作流程的高度相容性，有望推動核酸樣本製備耗材市場的發展。這使其成為臨床診斷和大規模檢測環境的理想選擇。此外，擴充性於多種樣本類型，且操作時間更短，因此可以重複使用耗材，進一步增強了其相對於二氧化矽基和其他技術的優勢。

細分 4：依下游應用

  • PCR
  • qPCR
  • NGS
  • 複製
  • 微陣列
  • 印跡法
  • 其他

qPCR 推動核酸樣品製備耗材市場（透過下游應用）。

從下游應用角度來看，qPCR 是臨床診斷、傳染病檢查和常規檢測流程中最常用的核酸檢測方法，並且由於其持續較高的樣本製備量，預計將引領核酸樣本製備耗材市場。

細分 5：依最終用戶

  • 學術研究機構和研究機構
  • 製藥和生物技術公司
  • 合約研究機構
  • 臨床診斷中心
  • 應用考試

核酸樣品製備耗材市場預計將由學術研究機構和實驗室（最終用戶）主導。

依最終用戶，學術研究機構和實驗室預計將推動全球核酸樣品製備耗材市場的發展，這主要得益於分子生物學研究的增加、對人類基因組研究日益成長的興趣、對提取高品質核酸的新技術的需求不斷擴大，以及對 NGS 和 PCR 等各種下游應用的資金投入增加。

細分 6：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 北美洲：美國、加拿大
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 波蘭
    • 葡萄牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 澳洲
    • 印度
    • 馬來西亞
    • 韓國
    • 泰國
    • 台灣
    • 新加坡
    • 印尼
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 智利
    • 哥倫比亞
    • 墨西哥
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

區域細分：北美是核酸樣本製備耗材市場的主要驅動力。

由於美國擁有眾多領先的市場參與企業，且提取的核酸在研究、診斷和合成生物學領域的應用日益廣泛，預計北美將引領全球核酸樣本製備耗材市場的發展。感染疾病、遺傳性疾病和慢性病的日益流行，以及新型樣本萃取試劑盒的研發，也是北美在全球核酸樣本製備耗材市場佔據主導地位的重要因素。

核酸樣品製備耗材市場近期趨勢

  • 2025年10月，AutoGen公司與Sampled公司達成合作，開始提供新一代核酸萃取和多組體學工作流程。根據該協議，Sampled公司將把複雜的提取計劃轉介給AutoGen公司，而AutoGen公司將大規模提取和下游分析外包給Sampled公司的一體化化驗服務。
  • 2025年 10月，LGC Biosearch Technologies, Inc. 在吉爾福德開設了一家新的國家實驗室，以支援更廣泛的研發和服務結構。
  • 2025年 9月，Promega 公司與 Watchmaker Genomics 公司合作，獲得了下一代改良型逆轉錄酶的許可，以提高 RNA 分析的性能。

需求 - 促進因素、挑戰與機會

市場促進因素

基因檢測數量不斷成長：基因檢測的快速發展是核酸樣本製備耗材市場的主要結構性促進因素。每項檢測都需要在分析前提取和純化高品質的DNA或RNA。該成長反映了基因檢測從小眾應用轉向臨床診斷、研究和個人化醫療的常規應用。由於大多數此類檢測都以臨床為導向，因此對萃取試劑盒、試劑和緩衝液等耗材的需求穩定。此外，檢測項目在多個疾病領域的擴展也增加了對標準化、可靠和規範的樣本製備流程的需求，進一步強化了對核酸檢體製備耗材的持續需求。

市場限制因素

保護基因組資料：人們對基因組資料的隱私、安全和倫理使用日益關注，這正成為核酸樣本製備耗材市場，特別是處理人類遺傳物質的工作流程中的主要阻礙因素。備受矚目的資料外洩事件揭露了基因組資料儲存和處理的漏洞，導致監管力度加大，並引發了經濟處罰。這些事件加劇了消費者和機構對敏感遺傳訊息（例如健康資料、祖源和家庭關係）被濫用的擔憂。因此，一些地區實施了更嚴格的資料保護條例，並對大規模基因組研究採取了更謹慎的態度。個人和機構參與基因檢測的意願日益降低，尤其是在監管不力的環境下，這可能會限制檢測的數量，抑制樣本製備工作流程中使用的核酸提取和純化耗材的需求。

市場機會

在政府、研究機構和慈善機構加大投資的推動下，生物樣本庫在醫學領域的發展和應用日益廣泛，為核酸樣本製備耗材帶來了巨大的市場機會。各地大規模生物銀行計畫正加速生物檢體的採集，提升長期儲存能力，並改善研究基礎設施。這些趨勢推動了對高品質DNA和RNA提取、穩定化和純化耗材的需求，而這些耗材對於大規模、長期的基因組研究非常重要。隨著生物樣本庫持續支持人口基因組學、精準醫療和縱向疾病研究，對標準化、自動化和高性能樣本製備耗材的需求不斷成長，這為市場帶來了強勁且長期的成長潛力。

這份報告將為組織帶來哪些附加價值？

產品與創新策略：全球核酸樣本製備耗材市場細分為多個關鍵部分，包括樣本來源類型、工作流程、技術、下游應用、終端使用者和區域市場。透過了解哪些細分市場佔據最大的市場佔有率以及哪些細分市場具有成長潛力，本報告為尋求產品創新和產品組合擴展的企業提供了寶貴的見解。

成長與行銷策略：策略夥伴關係、夥伴關係和業務擴張預計將在核酸樣本製備耗材市場的成長中發揮核心作用。診斷公司、醫療服務提供者和研究機構之間的關鍵進展和合作已開始成為市場動態的重要組成部分。

競爭策略：核酸樣本製備耗材市場競爭異常激烈，許多老字型大小企業都提供此類產品。主要參與企業致力於自動化耗材、高通量樣本處理以及標準化即用型試劑盒的創新。此外，各公司還強調透過提高效率、支援多種樣本類型以及與PCR和次世代定序等先進分子工作流程的無縫整合來實現產品差異化。

調查方法

市場設計與檢驗的關鍵考量與假設

  • 為了估算全球市場規模，涵蓋的期間為2024年至2035年，其中2024年為基準年，2025年至2035年為預測期。
  • 本報告的範圍基於來自各個行業的專家提供的全面資訊，包括臨床和診斷檢查室、生物技術和製藥公司、合約研究組織（CRO）、學術和研究機構以及基因組服務供應商。
  • 核酸樣本製備耗材的市場佔有率預計未來將大幅成長，這項預測是基於對現有解決方案的歷史資料分析得出的。
  • 每家公司的企業收益是根據其2023 會計年度和2024 會計年度的年度報告計算得出的。對於私人公司，企業收益估算來自一手研究資料、資金籌措歷史、市場合作關係和業務表現。
  • 本報告基於現有的核酸樣本製備耗材（包括萃取試劑盒、純化試劑和與工作流程相容的耗材）繪製了市場圖。報告還識別並介紹了該領域提供關鍵產品和服務的主要企業。

主要市場參與企業及競爭格局概述

本報告中包含的公司簡介是根據對每家公司的業務範圍、產品系列和市場滲透率的分析而選擇的。

該市場的主要企業包括以下幾家：

  • Agilent Technologies, Inc.
  • AutoGen Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Macherey-Nagel GmbH & Co KG
  • New England Biolabs
  • Norgen Biotek Corp
  • Omega Bio-tek, Inc.
  • QIAGEN NV
  • Revvity, Inc.（PerkinElmer, Inc.）
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Zymo Research
  • LGC Biosearch Technologies
  • Danaher Corporation

目錄

執行摘要

第1章 市場：產業展望

  • 市場概覽
  • 價格分析
  • 市場吸引力：宏觀與微觀因素分析
  • 監理展望
  • 主要趨勢
  • 市場動態

第2章 工作流程

  • 工作流程概要
  • 成長佔有率矩陣
  • 樣品的分離、萃取與純化
  • DNA/RNA純化與富集
  • DNA/RNA定量

第3章 依來源類型

  • 來源類型概述
  • 成長佔有率矩陣
  • DNA
    • 無細胞
    • 基因組
    • 微生物
    • 質體
    • 病毒性
    • RNA

第4章 技術

  • 技術概要
  • 成長佔有率矩陣
  • 二氧化矽基技術
  • 磁粉技術
  • 其他技術

第5章 下游應用

  • 下游應用概述
  • 成長佔有率矩陣
  • PCR
  • qPCR
  • NGS
  • 複製
  • 微陣列
  • 印跡技術
  • 其他

第6章 最終用戶

  • 最終用戶摘要
  • 成長佔有率矩陣
  • 學術研究機構和研究機構
  • 製藥和生物技術公司
  • 醫藥研發合約組織
  • 應用測試
  • 臨床診斷中心

第7章 區域

  • 區域概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 市場 - 競爭標竿分析與公司概況

  • 產品基準測試
  • 關鍵策略和企業發展（依公司）
  • 企業市場占有率分析
  • 公司簡介
    • Agilent Technologies, Inc.
    • AutoGen Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Macherey-Nagel GmbH & Co KG
    • New England Biolabs
    • Norgen Biotek Corp
    • Omega Bio-tek, Inc.
    • QIAGEN NV
    • Revvity, Inc.（PerkinElmer, Inc.）
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Zymo Research
    • LGC Biosearch Technologies
    • Danaher Corporation

第9章 調查方法

Product Code: BHL3511SA

This report can be delivered within 1 working day.

Introduction of the Nucleic Acid Sample Preparation Consumables Market

The global nucleic acid sample preparation consumables market, initially valued at $1,726.2 million in 2024, is projected to witness substantial growth, surging to $2,816.8 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 4.37% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$1,835.9 Million
2035 Forecast$2,816.8 Million
CAGR4.37%

The global nucleic acid sample preparation consumables market is witnessing robust growth, driven by the increasing demand for high-throughput, accurate, and scalable molecular workflows amid rising testing volumes and expanding applications in diagnostics and research. Nucleic acid sample preparation has become a critical upstream step across healthcare and life sciences, particularly in molecular diagnostics, infectious disease testing, oncology, and genomics research, where high-quality DNA and RNA extraction is essential for reliable downstream analysis. The growing prevalence of infectious diseases and cancer, along with the rising number of genetic tests and microbial sequencing applications, is further strengthening the role of sample preparation consumables across clinical laboratories, research institutes, and diagnostic settings. The integration of automation into sample preparation workflows is transforming conventional laboratory processes by enabling standardized extraction, reducing manual variability, and improving turnaround times. These consumables are particularly critical in high-volume environments such as clinical diagnostics and research laboratories, where consistency, scalability, and accuracy are essential. As healthcare and research systems shift toward precision medicine and operational efficiency, the adoption of advanced and automation-compatible consumables is accelerating to enhance reproducibility, optimize workflows, and support large-scale testing demands.

Technological advancements in reagent chemistry, magnetic particle-based technologies, and automation-compatible consumables are significantly enhancing sample preparation capabilities. Innovations focused on improving nucleic acid yield, purity, and consistency are enabling better performance in downstream applications such as qPCR and next-generation sequencing (NGS). In addition, the increasing integration of consumables with automated extraction platforms and standardized laboratory workflows is enabling scalable deployment across multi-site laboratories and supporting efficient, high-throughput operations. The growing emphasis on workflow standardization and interoperability across laboratory systems is further driving the transition from manual, fragmented processes to integrated, automation-driven sample preparation solutions. However, the market continues to face challenges, including high costs of consumables, stringent regulatory and quality compliance requirements, and the need for standardized workflows across diverse laboratory environments. Despite these challenges, increasing investments in genomics research, expansion of diagnostic infrastructure, and strategic collaborations among life sciences companies, research institutions, and healthcare providers are expected to drive sustained growth and innovation in the nucleic acid sample preparation consumables market.

Market Introduction

The global nucleic acid sample preparation consumables market has undergone a notable transformation, driven by continuous technological advancements and increasing integration of automation into laboratory workflows. Companies are progressively developing automation-compatible, ready-to-use consumables to enhance extraction efficiency, improve reproducibility, and reduce hands-on time in laboratory settings. These innovations support a wide range of applications, including molecular diagnostics, genomics, infectious disease testing, and precision medicine, enabling faster, more accurate, and standardized outcomes.

Key advancements, such as magnetic bead-based extraction technologies, high-efficiency reagent chemistries, and automation-ready kits, highlight the industry's focus on improving sample quality, minimizing contamination risks, and increasing processing throughput. Additionally, the integration of sample preparation consumables with automated platforms and digital laboratory systems is enhancing workflow efficiency, data consistency, and operational scalability across laboratories.

The growing demand for molecular testing, increasing research activity in genomics, and rising focus on early disease detection are further accelerating adoption across both developed and emerging markets. As healthcare and research ecosystems continue to prioritize accuracy, scalability, and efficiency, ongoing innovations in nucleic acid sample preparation consumables are expected to play a critical role in shaping the future of molecular diagnostics and life sciences workflows.

Industrial Impact

The global nucleic acid sample preparation consumables market has witnessed substantial growth, driven by the increasing adoption of molecular diagnostics, the rising prevalence of infectious diseases and cancer, and the expanding use of genomic technologies such as next-generation sequencing (NGS) and PCR-based applications. Key players such as Thermo Fisher Scientific Inc., Danaher Corporation, QIAGEN N.V., F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Promega Corporation, and LGC Biosearch Technologies are playing a pivotal role in advancing sample preparation technologies through continuous innovation and strategic investments.

These companies are actively focusing on the development of automation-compatible consumables, high-efficiency extraction kits, and advanced reagent chemistries, which are transforming sample preparation workflows and enabling high-throughput, reproducible, and scalable operations across clinical and research settings. Such innovations are improving nucleic acid yield, purity, and consistency, thereby enhancing the reliability of downstream applications such as qPCR and NGS.

At the same time, increasing demand from emerging markets is encouraging manufacturers to develop cost-effective, standardized, and easy-to-use consumables tailored to resource-constrained laboratory environments, thereby expanding access to molecular diagnostics and genomics research. Strategic collaborations between consumable manufacturers, diagnostic laboratories, research institutions, and automation solution providers are further supporting innovation and market expansion.

Additionally, the integration of sample preparation consumables with automated platforms and standardized workflows is improving laboratory efficiency, reducing hands-on time, and minimizing variability, thereby supporting high-volume testing environments. Overall, nucleic acid sample preparation consumables are enhancing workflow reliability, enabling scalable molecular testing, and supporting broader advancements across the genomics, diagnostics, and life sciences ecosystems.

Market Segmentation:

Segmentation 1: By Source Type

  • DNA
  • RNA

DNA Segment to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Source Type)

In terms of source type, the DNA segment is expected to lead the nucleic acid sample preparation consumables market, driven by increasing demand for high-grade DNA, availability of diverse DNA extraction kits worldwide, and massively growing demand for nucleic acid, particularly DNA, for different downstream processes such as NGS, PCR, cloning, and restriction enzyme analysis.

Segmentation 2: By Workflow

  • Sample Isolation/Extraction/Purification
  • DNA/RNA Clean-Up and Concentration
  • DNA/RNA Quantification

Sample Isolation/Extraction/Purification to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Workflow)

In terms of workflow, sample isolation/extraction/purification is expected to lead the nucleic acid sample preparation consumables market. These steps are highly consumable-intensive, involve multiple reagents and single-use components per sample, and scale directly with testing volumes.

Segmentation 3: By Technology

  • Silica-Based Technology
  • Magnetic Particle Technology
  • Other Technologies

Magnetic Particle Technology to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Technology)

In terms of technology, magnetic particle technology is expected to lead the nucleic acid sample preparation consumables market as it offers high binding efficiency, consistent yields, and strong compatibility with automated and high-throughput workflows, making it the preferred choice in clinical diagnostics and large-scale testing environments. In addition, its scalability across sample types and reduced hands-on time drive repeat consumable usage and reinforce its dominance over silica-based and alternative technologies.

Segmentation 4: By Downstream Application

  • PCR
  • qPCR
  • NGS
  • Cloning
  • Microarray
  • Blotting Techniques
  • Other Applications

qPCR to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Downstream Application)

In terms of downstream application, qPCR is expected to lead the nucleic acid sample preparation consumables market as it offers the most routinely used nucleic acid-based technique in clinical diagnostics, infectious disease testing, and routine laboratory workflows, driving consistently high sample volumes.

Segmentation 5: By End User

  • Academic Research Institutes and Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Clinical Diagnostic Centers
  • Applied Testing

Academic Research Institutes and Laboratories to Dominate the Nucleic Acid Sample Preparation Consumables Market (by End User)

In terms of end user, academic research institutes and laboratories are expected to lead the global nucleic acid sample preparation consumables market, driven by the rising research in the field of molecular biology, the growing interest in studying the human genome, the growing demand for novel techniques to extract high-quality nucleic material, and the rise in funding for various downstream applications, such as NGS and PCR.

Segmentation 6: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Poland
    • Portugal
    • Russia
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • Australia
    • India
    • Malaysia
    • South Korea
    • Thailand
    • Taiwan
    • Singapore
    • Indonesia
    • Philippines
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Argentina
    • Chile
    • Colombia
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest-of-Middle East and Africa

North America to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Region)

North America is expected to lead the global nucleic acid sample preparation consumables market, due to the presence of prominent market players in the U.S. and the rising number of applications of extracted nucleic acid in research, diagnostics, and synthetic biology. The growing prevalence of infectious diseases, genetic disorders, and chronic diseases, and the development of novel sample extraction kits are some of the factors that also lead to the dominance of North America in the global nucleic acid sample preparation consumables market.

Recent Developments in the Nucleic Acid Sample Preparation Consumables Market

  • In Oct 2025, AutoGen, Inc. partnered with Sampled to deliver next-generation nucleic acid extraction and multi-omic workflows. Under the agreement, Sampled refers complex extraction projects to AutoGen; AutoGen refers large-scale extraction and downstream analysis to Sampled's integrated laboratory services.
  • In Oct 2025, LGC Biosearch Technologies, Inc. opened a new National Laboratories facility in Guildford to support broader R&D and service capabilities.
  • In Sep 2025, Promega Corporation partnered with Watchmaker Genomics to license a next-generation engineered reverse transcriptase to enhance RNA analysis performance.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Growing Number of Genetic Tests: The rapid expansion in the number of genetic tests is a key structural driver for the nucleic acid sample preparation consumables market, as each test requires high-quality DNA or RNA extraction and purification prior to analysis. This growth reflects the transition of genetic testing from niche applications to routine use in clinical diagnostics, research, and personalized medicine. As most of these tests are clinically oriented, they generate consistent demand for consumables such as extraction kits, reagents, and buffers. Additionally, the expanding test menu across multiple disease areas is increasing the need for standardized, reliable, and regulatory-compliant sample preparation workflows, thereby reinforcing sustained and recurring demand for nucleic acid sample preparation consumables.

Market Restraints

Genomic Data Protection: Growing concerns around genomic data privacy, security, and ethical use are emerging as a key restraint for the nucleic acid sample preparation consumables market, particularly in workflows involving human genetic material. High-profile data breaches have exposed vulnerabilities in genomic data storage and handling, leading to increased regulatory scrutiny and financial penalties. These incidents have heightened consumer and institutional concerns regarding the misuse of sensitive genetic information, including health data, ancestry, and familial links. As a result, stricter data protection regulations and more cautious approaches toward large-scale genomic studies are being adopted in several regions. This growing hesitancy among individuals and institutions to participate in genetic testing, especially in less regulated environments, can limit testing volumes and, in turn, moderate the demand for nucleic acid extraction and purification consumables used in sample preparation workflows.

Market Opportunities

Development and Increased Utilization of Biobanks in the Healthcare Segment: The expanding development and utilization of biobanks represent a significant market opportunity for nucleic acid sample preparation consumables, driven by increasing investments from governments, research organizations, and philanthropic institutions. Large-scale biobanking initiatives across regions are accelerating biospecimen collection, enhancing long-term storage capabilities, and advancing research infrastructure. These developments are increasing demand for high-quality DNA and RNA extraction, stabilization, and purification consumables required for large-scale and long-duration genomic research. As biobanks continue to support population genomics, precision medicine, and longitudinal disease studies, they create recurring and sustained demand for standardized, automation-compatible, and high-performance sample preparation consumables, making this a strong and long-term growth opportunity in the market.

How can this report add value to an organization?

Product/Innovation Strategy: The global nucleic acid sample preparation consumables market has been divided into several key segments, including source type, workflow, technology, downstream application, end users, and regional markets. By understanding which segments hold the largest share and which ones show potential for growth, this report offers invaluable insights for organizations looking to innovate and expand their product offerings.

Growth/Marketing Strategy: Strategic partnerships, collaborations, and business expansions are anticipated to be central to the growth of the nucleic acid sample preparation consumables market. Key developments and partnerships among diagnostic companies, healthcare providers, and research institutions have already begun to form a significant part of the market dynamics.

Competitive Strategy: The nucleic acid sample preparation consumables market is highly competitive, with numerous well-established players offering nucleic acid sample preparation consumables. Key market participants are focusing on innovation in automation-compatible consumables, high-throughput sample processing, and standardized ready-to-use kits. Additionally, companies are emphasizing product differentiation through improved efficiency, compatibility with diverse sample types, and seamless integration with advanced molecular workflows such as PCR and next-generation sequencing.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2035 have been considered for the global market size estimation, 2024 has been considered as the base year, and 2025 to 2035 as the forecast period.
  • The scope of the report is based on comprehensive inputs from industry experts across various sectors, including clinical and diagnostic laboratories, biotechnology and pharmaceutical companies, contract research organizations (CROs), academic and research institutes, and genomics service providers.
  • The market contribution of nucleic acid sample preparation consumables is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2023 and FY2024. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing nucleic acid sample preparation consumables, including extraction kits, purification reagents, and workflow-compatible consumables. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts and key stakeholders across the life sciences and nucleic acid sample preparation consumables ecosystem, including consumable manufacturers, molecular diagnostics companies, and laboratory automation solution providers. Stakeholders such as clinical and diagnostic laboratories, biotechnology and pharmaceutical companies, academic and research institutes, and contract research organizations (CROs) have been consulted to validate adoption trends, workflow integration, and application-specific usage of sample preparation consumables. Respondents, including CEOs, vice presidents, product and marketing directors, laboratory managers, and genomics and molecular biology experts, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Agilent Technologies, Inc.
  • AutoGen Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Macherey-Nagel GmbH & Co KG
  • New England Biolabs
  • Norgen Biotek Corp
  • Omega Bio-tek, Inc.
  • QIAGEN N.V.
  • Revvity, Inc. (PerkinElmer, Inc.)
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Zymo Research
  • LGC Biosearch Technologies
  • Danaher Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Pricing Analysis
  • 1.3 Market Attractiveness: Macro and Micro Factor Analysis
  • 1.4 Regulatory Outlook
  • 1.5 Key Trends
    • 1.5.1 Transition from Episodic Diagnostic Testing to Longitudinal and Repeat Molecular Testing Workflows
    • 1.5.2 Real-World Data Points and Industry Instances
    • 1.5.3 Increasing Fragmentation of Sample Types Driving Demand for Application-Specific Consumables
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Growing Number of Genetic Tests
      • 1.6.1.2 Increasing Prevalence of Infectious Diseases and Cancer Cases
      • 1.6.1.3 Rise in Microbial Sequencing
      • 1.6.1.4 Increasing Adoption of NGS-Based Testing in Clinical Laboratories
    • 1.6.2 Market Restraints
      • 1.6.2.1 Genomic Data Protection
      • 1.6.2.2 High Cost of Nucleic Acid Sample Preparation Consumables
      • 1.6.2.3 Stringent Regulatory and Quality Compliance Requirements
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Development and Increased Utilization of Biobanks in the Healthcare Segment
      • 1.6.3.2 Shift toward Standardized, Ready-to-Use, and Automation-Compatible Sample Preparation Consumables

2 Workflow

  • 2.1 Workflow Summary
  • 2.2 Growth-Share Matrix
  • 2.3 Sample Isolation/Extraction/Purification
  • 2.4 DNA/RNA Clean-Up and Concentration
  • 2.5 DNA/RNA Quantification

3 Source Type

  • 3.1 Source Type Summary
  • 3.2 Growth-Share Matrix
  • 3.3 DNA
    • 3.3.1 Cell-Free
      • 3.3.1.1 Blood
      • 3.3.1.2 Serum/Plasma
      • 3.3.1.3 Other Sources
    • 3.3.2 Genomic
      • 3.3.2.1 Blood
      • 3.3.2.2 Body Fluids
      • 3.3.2.3 Buccal
      • 3.3.2.4 Cell/Cultured Cell
      • 3.3.2.5 FFPE
      • 3.3.2.6 Forensic
      • 3.3.2.7 Plant
      • 3.3.2.8 Saliva/Swab
      • 3.3.2.9 Serum/Plasma
      • 3.3.2.10 Tissue
      • 3.3.2.11 Stool, Urine, and Other Samples
    • 3.3.3 Microbe
      • 3.3.3.1 Bacterial
      • 3.3.3.2 Fungus
      • 3.3.3.3 Yeast
      • 3.3.3.4 Other Sources
    • 3.3.4 Plasmids
      • 3.3.4.1 GigaPrep
      • 3.3.4.2 MaxiPrep
      • 3.3.4.3 MegaPrep
      • 3.3.4.4 MidiPrep
      • 3.3.4.5 MiniPrep
    • 3.3.5 Viral
    • 3.3.6 RNA
      • 3.3.6.1 Genomic RNA
        • 3.3.6.1.1 Blood
        • 3.3.6.1.2 Body Fluids
        • 3.3.6.1.3 Cell/Cultured Cell
        • 3.3.6.1.4 FFPE
        • 3.3.6.1.5 Plant
        • 3.3.6.1.6 Saliva/Swab
        • 3.3.6.1.7 Serum/Plasma
        • 3.3.6.1.8 Tissue
        • 3.3.6.1.9 Urine
        • 3.3.6.1.10 Others
      • 3.3.6.2 Microbial RNA
        • 3.3.6.2.1 Bacteria
        • 3.3.6.2.2 Yeast
        • 3.3.6.2.3 Fungus
        • 3.3.6.2.4 Others
      • 3.3.6.3 Viral RNA
      • 3.3.6.4 Cell-Free RNA
        • 3.3.6.4.1 Serum/Plasma
        • 3.3.6.4.2 Others

4 Technology

  • 4.1 Technology Summary
  • 4.2 Growth-Share Matrix
  • 4.3 Silica-Based Technology
  • 4.4 Magnetic Particle Technology
  • 4.5 Other Technologies

5 Downstream Application

  • 5.1 Downstream Applications Summary
  • 5.2 Growth-Share Matrix
  • 5.3 PCR
  • 5.4 qPCR
  • 5.5 NGS
  • 5.6 Cloning
  • 5.7 Microarray
  • 5.8 Blotting Techniques
  • 5.9 Other Applications

6 End User

  • 6.1 End User Summary
  • 6.2 Growth-Share Matrix
  • 6.3 Academic Research Institutes and Laboratories
  • 6.4 Pharmaceutical and Biotechnology Companies
  • 6.5 Contract Research Organizations
  • 6.6 Applied Testing
  • 6.7 Clinical Diagnostic Centers

7 Region

  • 7.1 Regional Summary
  • 7.2 North America
    • 7.2.1 Regional Overview
    • 7.2.2 Driving Factors for Market Growth
    • 7.2.3 Factors Challenging the Market
    • 7.2.4 By Country
      • 7.2.4.1 U.S.
      • 7.2.4.2 Canada
  • 7.3 Europe
    • 7.3.1 Regional Overview
    • 7.3.2 Driving Factors for Market Growth
    • 7.3.3 Factors Challenging the Market
    • 7.3.4 By Country
      • 7.3.4.1 Germany
      • 7.3.4.2 U.K.
      • 7.3.4.3 France
      • 7.3.4.4 Italy
      • 7.3.4.5 Spain
      • 7.3.4.6 Netherlands
      • 7.3.4.7 Poland
      • 7.3.4.8 Portugal
      • 7.3.4.9 Russia
      • 7.3.4.10 Rest-of-Europe
  • 7.4 Asia Pacific
    • 7.4.1 Regional Overview
    • 7.4.2 Driving Factors for Market Growth
    • 7.4.3 Factors Challenging the Market
    • 7.4.4 By Country
      • 7.4.4.1 Australia
      • 7.4.4.2 China
      • 7.4.4.3 India
      • 7.4.4.4 Japan
      • 7.4.4.5 Malaysia
      • 7.4.4.6 South Korea
      • 7.4.4.7 Thailand
      • 7.4.4.8 Taiwan
      • 7.4.4.9 Singapore
      • 7.4.4.10 Indonesia
      • 7.4.4.11 Philippines
      • 7.4.4.12 Rest-of-Asia-Pacific
  • 7.5 Latin America
    • 7.5.1 Regional Overview
    • 7.5.2 Driving Factors for Market Growth
    • 7.5.3 Factors Challenging the Market
    • 7.5.4 By Country
      • 7.5.4.1 Argentina
      • 7.5.4.2 Brazil
      • 7.5.4.3 Chile
      • 7.5.4.4 Mexico
      • 7.5.4.5 Colombia
      • 7.5.4.6 Rest-of-Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Regional Overview
    • 7.6.2 Driving Factors for Market Growth
    • 7.6.3 Factors Challenging the Market
    • 7.6.4 By Country
      • 7.6.4.1 Saudi Arabia
      • 7.6.4.2 South Africa
      • 7.6.4.3 U.A.E.
      • 7.6.4.4 Rest-of-Middle East and Africa

8 Markets - Competitive Benchmarking & Company Profiles

  • 8.1 Product Benchmarking
    • 8.1.1 Product Benchmarking (by Source Type)
      • 8.1.1.1 DNA
      • 8.1.1.2 RNA
  • 8.2 Key Strategies and Developments (by Company)
    • 8.2.1 Partnerships, Collaborations, and Business Expansions
    • 8.2.2 New Offerings
  • 8.3 Company Share Analysis
    • 8.3.1 DNA
      • 8.3.1.1 Cell-Free DNA
      • 8.3.1.2 Genomic DNA
      • 8.3.1.3 Microbial DNA
      • 8.3.1.4 Plasmid DNA
      • 8.3.1.5 Viral DNA
    • 8.3.2 RNA
      • 8.3.2.1 Cell-Free RNA
      • 8.3.2.2 Genomic RNA
      • 8.3.2.3 Microbial RNA
      • 8.3.2.4 Viral RNA
  • 8.4 Company Profiles
    • 8.4.1 Agilent Technologies, Inc.
      • 8.4.1.1 Overview
      • 8.4.1.2 Top Products/Product Portfolio
      • 8.4.1.3 Top Competitors
      • 8.4.1.4 Target Customers
      • 8.4.1.5 Key Personnel
      • 8.4.1.6 Analyst View
    • 8.4.2 AutoGen Inc.
      • 8.4.2.1 Overview
      • 8.4.2.2 Top Products/Product Portfolio
      • 8.4.2.3 Top Competitors
      • 8.4.2.4 Target Customers
      • 8.4.2.5 Key Personnel
      • 8.4.2.6 Analyst View
    • 8.4.3 Bio-Rad Laboratories, Inc.
      • 8.4.3.1 Overview
      • 8.4.3.2 Top Products/Product Portfolio
      • 8.4.3.3 Top Competitors
      • 8.4.3.4 Target Customers
      • 8.4.3.5 Key Personnel
      • 8.4.3.6 Analyst View
    • 8.4.4 F. Hoffmann-La Roche AG
      • 8.4.4.1 Overview
      • 8.4.4.2 Top Products/Product Portfolio
      • 8.4.4.3 Top Competitors
      • 8.4.4.4 Target Customers
      • 8.4.4.5 Key Personnel
      • 8.4.4.6 Analyst View
    • 8.4.5 Merck KGaA
      • 8.4.5.1 Overview
      • 8.4.5.2 Top Products/Product Portfolio
      • 8.4.5.3 Top Competitors
      • 8.4.5.4 Target Customers
      • 8.4.5.5 Key Personnel
      • 8.4.5.6 Analyst View
    • 8.4.6 Macherey-Nagel GmbH & Co KG
      • 8.4.6.1 Overview
      • 8.4.6.2 Top Products/Product Portfolio
      • 8.4.6.3 Top Competitors
      • 8.4.6.4 Target Customers
      • 8.4.6.5 Key Personnel
      • 8.4.6.6 Analyst View
    • 8.4.7 New England Biolabs
      • 8.4.7.1 Overview
      • 8.4.7.2 Top Products/Product Portfolio
      • 8.4.7.3 Top Competitors
      • 8.4.7.4 Target Customers
      • 8.4.7.5 Key Personnel
      • 8.4.7.6 Analyst View
    • 8.4.8 Norgen Biotek Corp
      • 8.4.8.1 Overview
      • 8.4.8.2 Top Products/Product Portfolio
      • 8.4.8.3 Top Competitors
      • 8.4.8.4 Target Customers
      • 8.4.8.5 Key Personnel
      • 8.4.8.6 Analyst View
    • 8.4.9 Omega Bio-tek, Inc.
      • 8.4.9.1 Overview
      • 8.4.9.2 Top Products/Product Portfolio
      • 8.4.9.3 Top Competitors
      • 8.4.9.4 Target Customers
      • 8.4.9.5 Key Personnel
      • 8.4.9.6 Analyst View
    • 8.4.10 QIAGEN N.V.
      • 8.4.10.1 Overview
      • 8.4.10.2 Top Products/Product Portfolio
      • 8.4.10.3 Top Competitors
      • 8.4.10.4 Target Customers
      • 8.4.10.5 Key Personnel
      • 8.4.10.6 Analyst View
    • 8.4.11 Revvity, Inc. (PerkinElmer, Inc.)
      • 8.4.11.1 Overview
      • 8.4.11.2 Top Products/Product Portfolio
      • 8.4.11.3 Top Competitors
      • 8.4.11.4 Target Customers
      • 8.4.11.5 Key Personnel
      • 8.4.11.6 Analyst View
    • 8.4.12 Thermo Fisher Scientific Inc.
      • 8.4.12.1 Overview
      • 8.4.12.2 Top Products/Product Portfolio
      • 8.4.12.3 Top Competitors
      • 8.4.12.4 Target Customers
      • 8.4.12.5 Key Personnel
      • 8.4.12.6 Analyst View
    • 8.4.13 Promega Corporation
      • 8.4.13.1 Overview
      • 8.4.13.2 Top Products/Product Portfolio
      • 8.4.13.3 Top Competitors
      • 8.4.13.4 Target Customers
      • 8.4.13.5 Key Personnel
      • 8.4.13.6 Analyst View
    • 8.4.14 Zymo Research
      • 8.4.14.1 Overview
      • 8.4.14.2 Top Products/Product Portfolio
      • 8.4.14.3 Top Competitors
      • 8.4.14.4 Target Customers
      • 8.4.14.5 Key Personnel
      • 8.4.14.6 Analyst View
    • 8.4.15 LGC Biosearch Technologies
      • 8.4.15.1 Overview
      • 8.4.15.2 Top Products/Product Portfolio
      • 8.4.15.3 Top Competitors
      • 8.4.15.4 Target Customers
      • 8.4.15.5 Key Personnel
      • 8.4.15.6 Analyst View
    • 8.4.16 Danaher Corporation
      • 8.4.16.1 Overview
      • 8.4.16.2 Top Products/Product Portfolio
      • 8.4.16.3 Top Competitors
      • 8.4.16.4 Target Customers
      • 8.4.16.5 Key Personnel
      • 8.4.16.6 Analyst View

9 Research Methodology

  • 9.1 Data Sources
    • 9.1.1 Primary Data Sources
    • 9.1.2 Secondary Data Sources
    • 9.1.3 Data Triangulation
  • 9.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Nucleic Acid Sample Preparation Consumables Market (by Scenario), $Million, 2024, 2030, and 2035
  • Figure 2: Global Nucleic Acid Sample Preparation Consumables Market (by Region), $Million, 2024, 2030, and 2035
  • Figure 3: Global Nucleic Acid Sample Preparation Consumables Market (by Workflow), $Million, 2024, 2030, and 2035
  • Figure 4: Global Nucleic Acid Sample Preparation Consumables Market (by Source Type), $Million, 2024, 2030, and 2035
  • Figure 5: Global Nucleic Acid Sample Preparation Consumables Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 6: Global Nucleic Acid Sample Preparation Consumables Market (by Downstream Application), $Million, 2024, 2030, and 2035
  • Figure 7: Global Nucleic Acid Sample Preparation Consumables Market (by End User), $Million, 2024, 2030, and 2035
  • Figure 8: Global Nucleic Acid Sample Preparation Consumables Market, $Billion, 2018-2035
  • Figure 9: Global Cancer Incidence, 2018-2022
  • Figure 10: Global Nucleic Acid Sample Preparation Consumables Market (by Workflow), $Million, 2024, 2030, and 2035
  • Figure 11: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Consumables Market (by Workflow), 2024-2035
  • Figure 12: Global Nucleic Acid Sample Preparation Consumables Market (Sample Isolation/Extraction/Purification), $Million, 2024-2035
  • Figure 13: Global Nucleic Acid Sample Preparation Consumables Market (DNA/RNA Clean-Up and Concentration), $Million, 2024-2035
  • Figure 14: Global Nucleic Acid Sample Preparation Consumables Market (DNA/RNA Quantification), $Million, 2024-2035
  • Figure 15: Global Nucleic Acid Sample Preparation Consumables Market (by Source Type), $Million, 2024, 2030, and 2035
  • Figure 16: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Consumables Market (by Source Type), 2024-2035
  • Figure 17: Global Nucleic Acid Sample Preparation Consumables Market (DNA), $Million, 2024-2035
  • Figure 18: Global Nucleic Acid Sample Preparation Consumables Market (Cell-Free), $Million, 2024-2035
  • Figure 19: Global Nucleic Acid Sample Preparation Consumables Market (Blood), $Million, 2024-2035
  • Figure 20: Global Nucleic Acid Sample Preparation Consumables Market (Serum/Plasma), $Million, 2024-2035
  • Figure 21: Global Nucleic Acid Sample Preparation Consumables Market (Other Sources), $Million, 2024-2035
  • Figure 22: Global Nucleic Acid Sample Preparation Consumables Market (Genomic), $Million, 2024-2035
  • Figure 23: Global Nucleic Acid Sample Preparation Consumables Market (Blood), $Million, 2024-2035
  • Figure 24: Global Nucleic Acid Sample Preparation Consumables Market (Body Fluids), $Million, 2024-2035
  • Figure 25: Global Nucleic Acid Sample Preparation Consumables Market (Buccal), $Million, 2024-2035
  • Figure 26: Global Nucleic Acid Sample Preparation Consumables Market (Cell/Cultured Cell), $Million, 2024-2035
  • Figure 27: Global Nucleic Acid Sample Preparation Consumables Market (FFPE), $Million, 2024-2035
  • Figure 28: Global Nucleic Acid Sample Preparation Consumables Market (Forensic), $Million, 2024-2035
  • Figure 29: Global Nucleic Acid Sample Preparation Consumables Market (Plant), $Million, 2024-2035
  • Figure 30: Global Nucleic Acid Sample Preparation Consumables Market (Saliva/Swab), $Million, 2024-2035
  • Figure 31: Global Nucleic Acid Sample Preparation Consumables Market (Serum/Plasma), $Million, 2024-2035
  • Figure 32: Global Nucleic Acid Sample Preparation Consumables Market (Tissue), $Million, 2024-2035
  • Figure 33: Global Nucleic Acid Sample Preparation Consumables Market (Stool, Urine, and Other Samples), $Million, 2024-2035
  • Figure 34: Global Nucleic Acid Sample Preparation Consumables Market (Microbe), $Million, 2024-2035
  • Figure 35: Global Nucleic Acid Sample Preparation Consumables Market (Bacterial), $Million, 2024-2035
  • Figure 36: Global Nucleic Acid Sample Preparation Consumables Market (Fungus), $Million, 2024-2035
  • Figure 37: Global Nucleic Acid Sample Preparation Consumables Market (Yeast), $Million, 2024-2035
  • Figure 38: Global Nucleic Acid Sample Preparation Consumables Market (Other Sources), $Million, 2024-2035
  • Figure 39: Global Nucleic Acid Sample Preparation Consumables Market (Plasmids), $Million, 2024-2035
  • Figure 40: Global Nucleic Acid Sample Preparation Consumables Market (GigaPrep), $Million, 2024-2035
  • Figure 41: Global Nucleic Acid Sample Preparation Consumables Market (MaxiPrep), $Million, 2024-2035
  • Figure 42: Global Nucleic Acid Sample Preparation Consumables Market (MegaPrep), $Million, 2024-2035
  • Figure 43: Global Nucleic Acid Sample Preparation Consumables Market (MidiPrep), $Million, 2024-2035
  • Figure 44: Global Nucleic Acid Sample Preparation Consumables Market (MiniPrep), $Million, 2024-2035
  • Figure 45: Global Nucleic Acid Sample Preparation Consumables Market (Viral), $Million, 2024-2035
  • Figure 46: Global Nucleic Acid Sample Preparation Consumables Market (RNA), $Million, 2024-2035
  • Figure 47: Global Nucleic Acid Sample Preparation Consumables Market (Genomic RNA), $Million, 2024-2035
  • Figure 48: Global Nucleic Acid Sample Preparation Consumables Market (Blood), $Million, 2024-2035
  • Figure 49: Global Nucleic Acid Sample Preparation Consumables Market (Body Fluids), $Million, 2024-2035
  • Figure 50: Global Nucleic Acid Sample Preparation Consumables Market (Cell/Cultured Cell), $Million, 2024-2035
  • Figure 51: Global Nucleic Acid Sample Preparation Consumables Market (FFPE), $Million, 2024-2035
  • Figure 52: Global Nucleic Acid Sample Preparation Consumables Market (Plant), $Million, 2024-2035
  • Figure 53: Global Nucleic Acid Sample Preparation Consumables Market (Saliva/Swab), $Million, 2024-2035
  • Figure 54: Global Nucleic Acid Sample Preparation Consumables Market (Serum/Plasma), $Million, 2024-2035
  • Figure 55: Global Nucleic Acid Sample Preparation Consumables Market (Tissue), $Million, 2024-2035
  • Figure 56: Global Nucleic Acid Sample Preparation Consumables Market (Urine), $Million, 2024-2035
  • Figure 57: Global Nucleic Acid Sample Preparation Consumables Market (Others), $Million, 2024-2035
  • Figure 58: Global Nucleic Acid Sample Preparation Consumables Market (Microbial RNA), $Million, 2024-2035
  • Figure 59: Global Nucleic Acid Sample Preparation Consumables Market (Bacteria), $Million, 2024-2035
  • Figure 60: Global Nucleic Acid Sample Preparation Consumables Market (Yeast), $Million, 2024-2035
  • Figure 61: Global Nucleic Acid Sample Preparation Consumables Market (Fungus), $Million, 2024-2035
  • Figure 62: Global Nucleic Acid Sample Preparation Consumables Market (Others), $Million, 2024-2035
  • Figure 63: Global Nucleic Acid Sample Preparation Consumables Market (Viral RNA), $Million, 2024-2035
  • Figure 64: Global Nucleic Acid Sample Preparation Consumables Market (Cell-Free RNA), $Million, 2024-2035
  • Figure 65: Global Nucleic Acid Sample Preparation Consumables Market (Serum/Plasma), $Million, 2024-2035
  • Figure 66: Global Nucleic Acid Sample Preparation Consumables Market (Others), $Million, 2024-2035
  • Figure 67: Global Nucleic Acid Samples Preparation Consumables Market (by Technology), $Million, 2024, 2030, and 2035
  • Figure 68: Growth-Share Analysis for Global Nucleic Acid Samples Preparation Consumables Market (by Technology), 2024-2035
  • Figure 69: Global Nucleic Acid Samples Preparation Consumables Market (Silica-Based Technology), $Million, 2024-2035
  • Figure 70: Global Nucleic Acid Samples Preparation Consumables Market (Magnetic Particle Technology), $Million, 2024-2035
  • Figure 71: Global Nucleic Acid Samples Preparation Consumables Market (Other Technologies), $Million, 2024-2035
  • Figure 72: Global Nucleic Acid Samples Preparation Consumables Market (by Downstream Applications), $Million, 2024, 2030, and 2035
  • Figure 73: Growth-Share Analysis for Nucleic Acid Samples Preparation Consumables Market (by Downstream Applications), 2024-2035
  • Figure 74: Global Nucleic Acid Sample Preparation Consumables Market (PCR), $Million, 2024-2035
  • Figure 75: Global Nucleic Acid Sample Preparation Consumables Market (qPCR), $Million, 2024-2035
  • Figure 76: Global Nucleic Acid Sample Preparation Consumables Market (NGS), $Million, 2024-2035
  • Figure 77: Global Nucleic Acid Sample Preparation Consumables Market (Cloning), $Million, 2024-2035
  • Figure 78: Global Nucleic Acid Sample Preparation Consumables Market (Microarray), $Million, 2024-2035
  • Figure 79: Global Nucleic Acid Sample Preparation Consumables Market (Blotting Techniques), $Million, 2024-2035
  • Figure 80: Global Nucleic Acid Sample Preparation Consumables Market (Other Applications), $Million, 2024-2035
  • Figure 81: Global Nucleic Acid Samples Preparation Consumables Market (by End User), $Million, 2024-2035
  • Figure 82: Growth-Share Analysis for Global Nucleic Acid Samples Preparation Consumables Market (by End User), 2024-2035
  • Figure 83: Global Nucleic Acid Samples Preparation Consumables Market (Academic Research Institutes and Laboratories), $Million, 2024-2035
  • Figure 84: Global Nucleic Acid Samples Preparation Consumables Market (Pharmaceutical and Biotechnology Companies), $Million, 2024-2035
  • Figure 85: Global Nucleic Acid Samples Preparation Consumables Market (Contract Research Organizations), $Million, 2024-2035
  • Figure 86: Global Nucleic Acid Samples Preparation Consumables Market (Applied Testing), $Million, 2024-2035
  • Figure 87: Global Nucleic Acid Samples Preparation Consumables Market (Clinical Diagnostic Centers), $Million, 2024-2035
  • Figure 88: North America Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 89: U.S. Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 90: Canada Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 91: Europe Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 92: Germany Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 93: U.K. Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 94: France Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 95: Italy Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 96: Spain Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 97: Netherlands Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 98: Poland Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 99: Portugal Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 100: Russia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 101: Rest-of-Europe Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 102: Asia Pacific Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 103: Australia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 104: China Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 105: India Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 106: Japan Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 107: Malaysia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 108: South Korea Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 109: Thailand Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 110: Taiwan Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 111: Singapore Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 112: Indonesia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 113: Philippines Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 114: Rest-of-Asia-Pacific Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 115: Latin America Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 116: Argentina Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 117: Brazil Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 118: Chile Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 119: Mexico Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 120: Colombia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 121: Rest-of-Latin America Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 122: Middle East and Africa Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 123: Saudi Arabia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 124: South Africa Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 125: U.A.E Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 126: Rest-of-Middle East and Africa Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2035
  • Figure 127: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (DNA)
  • Figure 128: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Cell-Free DNA)
  • Figure 129: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Genomic DNA)
  • Figure 130: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Microbial DNA)
  • Figure 131: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Plasmid DNA)
  • Figure 132: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Viral DNA)
  • Figure 133: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (RNA)
  • Figure 134: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Cell-Free RNA)
  • Figure 135: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Genomic RNA)
  • Figure 136: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Microbial RNA)
  • Figure 137: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Viral RNA)
  • Figure 138: Data Triangulation
  • Figure 139: Top-Down and Bottom-Up Approach
  • Figure 140: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Pricing of Market Available Consumables
  • Table 3: Global Nucleic Acid Sample Preparation Consumables Market, Market Attractiveness
  • Table 4: Global Nucleic Acid Sample Preparation Consumables Market Regulatory Landscape in U.S., EU, Japan, China, and India
  • Table 5: Impact Analysis of Market Dynamics, 2024-2035
  • Table 6: Global Nucleic Acid Sample Preparation Consumables Market (by Region), $Million, 2024-2035
  • Table 7: Nucleic Acid Sample Preparation Consumables Market, Product Benchmarking (by Source Type, DNA)
  • Table 8: Nucleic Acid Sample Preparation Consumables Market, Product Benchmarking (by Source Type, DNA)